Hair Regrowth
•Last Updated: April 29 2017
Hair regrowth refers to the rate of which hair grows, and may also refer to attenuating or reversing forms of alopecia (hair loss). These supplements can be both ingested or applied topically to the scalp.
Last Updated: April 29 2017
Participants: 1778
Participants: 35
Participants: 15
Participants: 100
What works and what doesn't?
Unlock the full potential of Examine
2.^Price VHTestosterone metabolism in the skin. A review of its function in androgenetic alopecia, acne vulgaris, and idiopathic hirsutism including recent studies with antiandrogensArch Dermatol.(1975 Nov)
3.^Whiting DADiagnostic and predictive value of horizontal sections of scalp biopsy specimens in male pattern androgenetic alopeciaJ Am Acad Dermatol.(1993 May)
5.^Yamamoto K, Taketomi Y, Isogai Y, Miki Y, Sato H, Masuda S, Nishito Y, Morioka K, Ishimoto Y, Suzuki N, Yokota Y, Hanasaki K, Ishikawa Y, Ishii T, Kobayashi T, Fukami K, Ikeda K, Nakanishi H, Taguchi R, Murakami MHair follicular expression and function of group X secreted phospholipase A2 in mouse skinJ Biol Chem.(2011 Apr 1)
6.^Colombe L, Vindrios A, Michelet JF, Bernard BAProstaglandin metabolism in human hair follicleExp Dermatol.(2007 Sep)
7.^Garza LA, Liu Y, Yang Z, Alagesan B, Lawson JA, Norberg SM, Loy DE, Zhao T, Blatt HB, Stanton DC, Carrasco L, Ahluwalia G, Fischer SM, FitzGerald GA, Cotsarelis GProstaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopeciaSci Transl Med.(2012 Mar 21)
8.^Chen W, Tsai SJ, Wang CA, Tsai JC, Zouboulis CCHuman sebocytes express prostaglandin E2 receptors EP2 and EP4 but treatment with prostaglandin E2 does not affect testosterone productionBr J Dermatol.(2009 Sep)
9.^Bauman DR, Steckelbroeck S, Penning TMThe roles of aldo-keto reductases in steroid hormone actionDrug News Perspect.(2004 Nov)
10.^Kvedar JC, Baden HP, Levine LSelective inhibition by minoxidil of prostacyclin production by cells in cultureBiochem Pharmacol.(1988 Mar 1)
11.^Torii E, Segi E, Sugimoto Y, Takahashi K, Kabashima K, Ikai K, Ichikawa AExpression of prostaglandin E(2) receptor subtypes in mouse hair folliclesBiochem Biophys Res Commun.(2002 Jan 18)
12.^Müller-Decker K, Leder C, Neumann M, Neufang G, Bayerl C, Schweizer J, Marks F, Fürstenberger GExpression of cyclooxygenase isozymes during morphogenesis and cycling of pelage hair follicles in mouse skin: precocious onset of the first catagen phase and alopecia upon cyclooxygenase-2 overexpressionJ Invest Dermatol.(2003 Oct)
15.^Sasaki S, Hozumi Y, Kondo SInfluence of prostaglandin F2alpha and its analogues on hair regrowth and follicular melanogenesis in a murine modelExp Dermatol.(2005 May)
16.^Samuelsson B, Goldyne M, Granström E, Hamberg M, Hammarström S, Malmsten CProstaglandins and thromboxanesAnnu Rev Biochem.(1978)
17.^Uno H, Zimbric ML, Albert DM, Stjernschantz JEffect of latanoprost on hair growth in the bald scalp of the stump-tailed macacque: a pilot studyActa Derm Venereol.(2002)
19.^Blume-Peytavi U, Lönnfors S, Hillmann K, Garcia Bartels NA randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopeciaJ Am Acad Dermatol.(2012 May)
20.^Bellandi S, Amato L, Cipollini EM, Antiga E, Brandini L, Fabbri PRepigmentation of hair after latanoprost therapyJ Eur Acad Dermatol Venereol.(2011 Dec)
22.^Thigpen AE, Silver RI, Guileyardo JM, Casey ML, McConnell JD, Russell DWTissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expressionJ Clin Invest.(1993 Aug)
23.^Kaufman KD, Dawber RPFinasteride, a Type 2 5alpha-reductase inhibitor, in the treatment of men with androgenetic alopeciaExpert Opin Investig Drugs.(1999 Apr)
24.^Arif T, Dorjay K, Adil M, Sami MDutasteride in Androgenetic Alopecia: An UpdateCurr Clin Pharmacol.(2017)
25.^Walsh PC, Madden JD, Harrod MJ, Goldstein JL, MacDonald PC, Wilson JDFamilial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadiasN Engl J Med.(1974 Oct 31)
26.^Imperato-McGinley J, Guerrero L, Gautier T, Peterson RESteroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditismScience.(1974 Dec 27)
27.^Winiarska A, Mandt N, Kamp H, Hossini A, Seltmann H, Zouboulis CC, Blume-Peytavi UEffect of 5alpha-dihydrotestosterone and testosterone on apoptosis in human dermal papilla cellsSkin Pharmacol Physiol.(2006)
28.^Inui S, Itami SMolecular basis of androgenetic alopecia: From androgen to paracrine mediators through dermal papillaJ Dermatol Sci.(2011 Jan)
29.^Zhu H, Ma H, Ni H, Ma XH, Mills N, Yang ZMExpression and regulation of lipocalin-type prostaglandin d synthase in rat testis and epididymisBiol Reprod.(2004 Apr)
30.^Treister NS, Richards SM, Suzuki T, Jensen RV, Sullivan DAInfluence of androgens on gene expression in the BALB/c mouse submandibular glandJ Dent Res.(2005 Dec)
31.^Nagata K, Tanaka K, Ogawa K, Kemmotsu K, Imai T, Yoshie O, Abe H, Tada K, Nakamura M, Sugamura K, Takano SSelective expression of a novel surface molecule by human Th2 cells in vivoJ Immunol.(1999 Feb 1)
32.^Hirai H, Tanaka K, Yoshie O, Ogawa K, Kenmotsu K, Takamori Y, Ichimasa M, Sugamura K, Nakamura M, Takano S, Nagata KProstaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2J Exp Med.(2001 Jan 15)
33.^Neufang G, Furstenberger G, Heidt M, Marks F, Müller-Decker KAbnormal differentiation of epidermis in transgenic mice constitutively expressing cyclooxygenase-2 in skinProc Natl Acad Sci U S A.(2001 Jun 19)
34.^Bol DK, Rowley RB, Ho CP, Pilz B, Dell J, Swerdel M, Kiguchi K, Muga S, Klein R, Fischer SMCyclooxygenase-2 overexpression in the skin of transgenic mice results in suppression of tumor developmentCancer Res.(2002 May 1)